Undruggable Proteins Trend 2026

Proteins that resist conventional drug binding are termed undruggable. Scientists are circumventing this challenge using targeted protein degradation and molecular glues, effectively dismantling these elusive disease drivers. This breakthrough primarily benefits oncology patients and those with rare genetic disorders, offering new therapeutic hope where traditional small-molecule inhibitors have failed, fundamentally reshaping drug discovery.